Egypt is looking to Luxor to help attract more patients from abroad, adding medical treatment to the city’s established trade in cultural tourism.
Six hospitals in Luxor offer hotel-style suites, according to a Bloomberg report republished by BusinessMirror. The initiative forms part of Egypt’s effort to compete with Turkey and the United Arab Emirates for international patients.
Egypt Healthcare Authority facilities treated 13,370 foreign patients in 2025, up from 2,075 in 2022, according to figures the authority supplied to Bloomberg. Chairman Ahmed El-Sobky expects revenue from medical visits to reach $6 million in 2026, compared with $3.8 million last year—a projected increase of about 58%.
Those figures cover the authority’s facilities. They don’t measure Egypt’s entire medical tourism market, which lacks a consolidated national revenue total.
“Breaking into established patient flows is the real battle,” Emre Atceken, co-founder of medical travel company WeCure, told Bloomberg.
The figures also leave a basic question unanswered: how many foreign patients traveled to Egypt specifically for treatment? Counting foreign nationals receiving care isn’t necessarily the same as counting medical tourists. Without that distinction, readers can’t tell how much of the increase represents new demand from overseas.
Egypt is also working on how patients arrange their care. In a January announcement about its “In Egypt We Care” platforms, the State Information Service described a service intended to support patients from their first inquiry through treatment and follow-up.
That promise needs to translate into clear arrangements before anyone books a flight. Patients need to know which doctor will assess them, what the quoted price covers and who will handle problems after discharge.
The World Medical Association’s guidance on medical tourism calls for a treatment plan and cost estimate before travel. It also recommends that patients receive information about their legal rights and that clinicians in both countries coordinate follow-up care where possible.
Luxor’s tourism appeal adds another consideration. A hospital stay and a sightseeing trip don’t necessarily fit the same schedule.
The US Centers for Disease Control and Prevention warns that long tours, swimming and strenuous activity after surgery can interfere with healing. Surgery and air travel also increase the risk of blood clots. These risks apply to medical travel generally; they are not findings about hospitals in Luxor.
A patient planning to visit the city’s monuments after treatment therefore needs advice from the treating clinician about what is safe and when. Leaving hospital doesn’t automatically mean being ready for a tour or a flight home.
The same planning applies to costs. The CDC advises patients to establish where follow-up will take place, how complications will be managed and whether additional care carries extra charges. Patients should also obtain copies of their medical records for clinicians at home.
Egypt’s expansion has implications for local patients, too. The World Medical Association says medical tourism should not reduce residents’ access to care, particularly where staff or treatment capacity is limited.
For Luxor, measuring that impact will require more than foreign patient totals. Waiting times for residents, staffing levels and treatment outcomes would show whether investment is improving care alongside attracting revenue. For patients choosing a hospital, the questions are immediate: who will treat them if something goes wrong, who will pay, and who will take over their care when they return home?